Masataka Suzuki

Masataka Suzuki is an Associate Professor at Baylor College of Medicine, affiliated with the Center for Gene Therapy and the Dan L Duncan Comprehensive Cancer Center. His research focuses on cancer immunotherapy, particularly combining oncolytic virotherapy with CAR-T cell therapy to target solid tumors. He explores strategies such as cytokine delivery, checkpoint inhibitors, and BiTE molecules to enhance therapeutic efficacy while evaluating tumor immune microenvironments using humanized mouse models.

His work emphasizes translational research, including preclinical and clinical studies of ultralow-dose adenoviral vectors. Key projects include in vivo CAR-T cell generation using viral vectors and investigating heterogeneous tumor responses to combination therapies.

Publications highlight advancements in modulating immune systems to combat pancreatic tumors and metastatic cancers, demonstrating expertise in viral vector engineering and immunotherapeutic synergy.

While no awards or grants are explicitly listed, his contributions to the field are evident through his active research projects and peer-reviewed publications.